Rafic Farah

716 total citations
31 papers, 408 citations indexed

About

Rafic Farah is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Rafic Farah has authored 31 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Oncology and 7 papers in Genetics. Recurrent topics in Rafic Farah's work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). Rafic Farah is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). Rafic Farah collaborates with scholars based in United States and France. Rafic Farah's co-authors include Kathleen Dorritie, Anastasios Raptis, Mounzer Agha, Annie Im, Jing‐Zhou Hou, Michael Boyiadzis, Alison R. Sehgal, Robert L. Redner, Seah H. Lim and M. Hong Nguyen and has published in prestigious journals such as Blood, Cancer and Clinical Infectious Diseases.

In The Last Decade

Rafic Farah

27 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rafic Farah United States	11	254	163	102	77	64	31	408
Michael A. Spinner United States	10	276 1.1×	137 0.8×	69 0.7×	218 2.8×	58 0.9×	35	481
Folashade Otegbeye United States	10	316 1.2×	239 1.5×	135 1.3×	40 0.5×	126 2.0×	57	517
Ben Carpenter United Kingdom	11	160 0.6×	128 0.8×	77 0.8×	27 0.4×	30 0.5×	28	320
Geothy Chakupurakal Germany	12	126 0.5×	157 1.0×	156 1.5×	53 0.7×	31 0.5×	28	369
Maite Encuentra Spain	9	162 0.6×	84 0.5×	77 0.8×	110 1.4×	20 0.3×	18	326
Jeremy Ramdial United States	10	129 0.5×	63 0.4×	121 1.2×	86 1.1×	39 0.6×	62	310
Nan Young Lee South Korea	14	174 0.7×	176 1.1×	306 3.0×	56 0.7×	120 1.9×	41	545
Byoung Kook Kim South Korea	12	135 0.5×	84 0.5×	192 1.9×	93 1.2×	73 1.1×	43	410
Odit Gutwein Israel	8	193 0.8×	157 1.0×	121 1.2×	28 0.4×	90 1.4×	17	415
Stéphanie Nguyen Quoc France	9	230 0.9×	129 0.8×	91 0.9×	131 1.7×	44 0.7×	14	422

Countries citing papers authored by Rafic Farah

Since Specialization

Citations

This map shows the geographic impact of Rafic Farah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafic Farah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafic Farah more than expected).

Fields of papers citing papers by Rafic Farah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafic Farah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafic Farah. The network helps show where Rafic Farah may publish in the future.

Co-authorship network of co-authors of Rafic Farah

This figure shows the co-authorship network connecting the top 25 collaborators of Rafic Farah. A scholar is included among the top collaborators of Rafic Farah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafic Farah. Rafic Farah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iasella, Carlo J., Norihisa Shigemura, Pablo G. Sánchez, et al.. (2025). Belatacept as an alternative immunosuppressive agent for bone marrow-sparing in idiopathic pulmonary fibrosis lung transplant recipients with short telomeres. The Journal of Heart and Lung Transplantation. 44(10). 1659–1662.

Im, Annie, Kevin Quann, Mounzer Agha, et al.. (2024). Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients. American Journal of Hematology. 99(3). 380–386. 1 indexed citations

Iasella, Carlo J., Iulia Popescu, Robin Burke, et al.. (2023). Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications. American Journal of Transplantation. 23(10). 1590–1602. 9 indexed citations

Kleinberger, Jeffrey W., Bryan Rea, Nidhi Aggarwal, et al.. (2023). Novel <i>FIP1L1::KIT</i> fusion in a myeloid neoplasm with eosinophilia, T-lymphoblastic transformation, and dasatinib response. Haematologica. 108(11). 3181–3185.

Aarabi, Mahmoud, et al.. (2022). A Novel Integrated Approach for Cytogenomic Evaluation of Plasma Cell Neoplasms. Journal of Molecular Diagnostics. 24(10). 1067–1078.

Prockop, Susan E., Amer Beitinjaneh, Sylvain Choquet, et al.. (2022). S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE). HemaSphere. 6. 157–158. 2 indexed citations

Posluszny, Donna M., Dana H. Bovbjerg, Karen L. Syrjala, et al.. (2021). Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers. Transplantation and Cellular Therapy. 28(3). 165.e1–165.e9. 10 indexed citations

Agha, Mounzer, Anastasios Raptis, Jing‐Zhou Hou, et al.. (2021). A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy. Supportive Care in Cancer. 30(2). 1673–1679. 11 indexed citations

Lontos, Konstantinos, Jonathan G. Yabes, Rafic Farah, & Michael Boyiadzis. (2020). Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma. Leukemia. 35(4). 1193–1196. 4 indexed citations

10.

Cooper, Jason P., Rafic Farah, Philip A. Stevenson, et al.. (2019). Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab. Biology of Blood and Marrow Transplantation. 25(7). 1331–1339. 14 indexed citations

11.

Melani, Christopher, Stefania Pittaluga, Miloš D. Miljković, et al.. (2019). Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis. Blood. 134(Supplement_1). 2867–2867. 2 indexed citations

12.

Redner, Robert L., Jan H. Beumer, Patricia Kropf, et al.. (2018). A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Leukemia & lymphoma. 59(11). 2595–2601. 10 indexed citations

13.

Boyiadzis, Michael, Mounzer Agha, Robert L. Redner, et al.. (2017). Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. Cytotherapy. 19(10). 1225–1232. 139 indexed citations

14.

Lontos, Konstantinos, Mounzer Agha, Anastasios Raptis, et al.. (2017). Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation. Clinical Transplantation. 31(9). 1 indexed citations

15.

Agha, Mounzer, Anastasios Raptis, Jing‐Zhou Hou, et al.. (2016). Leukapheresis in patients newly diagnosed with acute myeloid leukemia. Transfusion and Apheresis Science. 55(2). 216–220. 20 indexed citations

16.

Roth, Christine G., Amanda Gillespie-Twardy, Stanley M. Marks, et al.. (2016). Flow Cytometric Evaluation of Double/Triple Hit Lymphoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 23(3). 137–146. 14 indexed citations

17.

Im, Annie, Ali Imran Amjad, Mounzer Agha, et al.. (2016). Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 24(2). 73–80. 10 indexed citations

18.

Raptis, Anastasios, Jing‐Zhou Hou, Rafic Farah, et al.. (2015). Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant. European Journal Of Haematology. 96(1). 55–59. 1 indexed citations

19.

Raptis, Anastasios, Jing‐Zhou Hou, Rafic Farah, et al.. (2015). Inferior outcome after allogeneic transplant in first remission in high‐risk AML patients who required more than two cycles of induction therapy. American Journal of Hematology. 90(8). 715–718. 6 indexed citations

20.

Ross, Kelly, Amanda Gillespie-Twardy, Mounzer Agha, et al.. (2015). Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid Leukemia. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 22(2). 85–92. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact